Gupta R, Fielder T, Bal M, Chiosea S, Dahlstrom J, Kakkar A
Head Neck Pathol. 2025; 19(1):20.
PMID: 39918634
PMC: 11805726.
DOI: 10.1007/s12105-025-01753-7.
Rhutso Y, Kakoti L, Sharma J, Kalita M
South Asian J Cancer. 2022; 11(2):140-145.
PMID: 36466975
PMC: 9718598.
DOI: 10.1055/s-0041-1736201.
Popov T, Stancheva G, Kyurkchiyan S, Petkova V, Panova S, Kaneva R
Sci Rep. 2022; 12(1):17051.
PMID: 36224266
PMC: 9556831.
DOI: 10.1038/s41598-022-20338-w.
Meccariello G, Catalano A, Cammaroto G, Iannella G, Vicini C, Hao S
Medicina (Kaunas). 2022; 58(8).
PMID: 36013517
PMC: 9415053.
DOI: 10.3390/medicina58081050.
Voss J, Freund L, Neumann F, Mrosk F, Rubarth K, Kreutzer K
Clin Oral Investig. 2022; 26(11):6711-6720.
PMID: 35895143
PMC: 9643253.
DOI: 10.1007/s00784-022-04630-7.
Selective Neck Dissection and Survival in Pathologically Node-Positive Oral Squamous Cell Carcinoma.
Shimura S, Ogi K, Miyazaki A, Shimizu S, Kaneko T, Sonoda T
Cancers (Basel). 2019; 11(2).
PMID: 30823588
PMC: 6406756.
DOI: 10.3390/cancers11020269.
Examining adjuvant radiation dose in head and neck squamous cell carcinoma.
Avkshtol V, Handorf E, Ridge J, Leachman B, Liu J, Bauman J
Head Neck. 2019; 41(7):2133-2142.
PMID: 30737968
PMC: 7830814.
DOI: 10.1002/hed.25680.
A novel histopathological scoring system for patients with oral squamous cell carcinoma.
Safi A, Grochau K, Drebber U, Schick V, Thiele O, Backhaus T
Clin Oral Investig. 2019; 23(10):3759-3765.
PMID: 30673863
DOI: 10.1007/s00784-019-02804-4.
Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.
Johnstone P, Boulware D, Djajadiningrat R, Ottenhof S, Necchi A, Catanzaro M
Eur Urol Focus. 2018; 5(5):737-741.
PMID: 30327282
PMC: 7771242.
DOI: 10.1016/j.euf.2018.10.007.
AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma.
Fulcher C, Haigentz Jr M, Ow T
Head Neck. 2017; 40(4):676-686.
PMID: 29171929
PMC: 5849482.
DOI: 10.1002/hed.25025.
A critical evaluation of lymph node ratio in head and neck cancer.
de Ridder M, Marres C, Smeele L, van den Brekel M, Hauptmann M, Balm A
Virchows Arch. 2016; 469(6):635-641.
PMID: 27639568
DOI: 10.1007/s00428-016-2015-9.
Analysis of the invasive edge in primary and secondary oral squamous cell carcinoma: An independent prognostic marker: A retrospective study.
Nadaf A, Bavle R, Soumya M, Dmello S, Kuriakose M, Govindan S
J Oral Maxillofac Pathol. 2016; 20(2):239-45.
PMID: 27601816
PMC: 4989554.
DOI: 10.4103/0973-029X.185931.
Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.
Leon X, Diez S, Garcia J, Lop J, Sumarroca A, Quer M
Eur Arch Otorhinolaryngol. 2016; 273(12):4525-4533.
PMID: 27328961
DOI: 10.1007/s00405-016-4144-9.
Predictive factors of occult neck metastasis in patients with oral squamous cell carcinoma.
Bittar R, Ferraro H, Ribas M, Lehn C
Braz J Otorhinolaryngol. 2016; 82(5):543-7.
PMID: 26749457
PMC: 9444684.
DOI: 10.1016/j.bjorl.2015.09.005.
Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma.
Adel M, Kao H, Hsu C, Huang J, Lee L, Huang Y
Medicine (Baltimore). 2015; 94(43):e1510.
PMID: 26512553
PMC: 4985367.
DOI: 10.1097/MD.0000000000001510.
Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis.
Cantrell S, Reid H, Li G, Wei Q, Sturgis E, Ginsberg L
J Comput Assist Tomogr. 2014; 38(5):667-73.
PMID: 24943254
PMC: 4318505.
DOI: 10.1097/RCT.0000000000000100.
Silencing Met receptor tyrosine kinase signaling decreased oral tumor growth and increased survival of nude mice.
Tao X, Hill K, Gaziova I, Sastry S, Qui S, Szaniszlo P
Oral Oncol. 2013; 50(2):104-12.
PMID: 24268630
PMC: 4097605.
DOI: 10.1016/j.oraloncology.2013.10.014.
Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era.
Vila P, Stucken C, Morris L, Posner M, Genden E, Boffetta P
Eur Arch Otorhinolaryngol. 2013; 271(9):2523-9.
PMID: 24190760
PMC: 4010562.
DOI: 10.1007/s00405-013-2796-2.
Differences in imaging characteristics of HPV-positive and HPV-Negative oropharyngeal cancers: a blinded matched-pair analysis.
Cantrell S, Peck B, Li G, Wei Q, Sturgis E, Ginsberg L
AJNR Am J Neuroradiol. 2013; 34(10):2005-9.
PMID: 23660291
PMC: 3951375.
DOI: 10.3174/ajnr.A3524.
Receptor-tyrosine-kinase-targeted therapies for head and neck cancer.
Elferink L, Resto V
J Signal Transduct. 2011; 2011:982879.
PMID: 21776391
PMC: 3135278.
DOI: 10.1155/2011/982879.